PADCEV
PADCEV
Approved
DIN Number
02521903
Drug Class
Human
Market Date
Dec 20, 2021
Company
HC
Seagen Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02521903
AIG Number0163254001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FX13 ENFORTUMAB VEDOTIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ENFORTUMAB VEDOTINActive
Strength: 20 MG / VIAL
Monograph: ENFORTUMAB VEDOTIN